Both in Pharmaceuticals
Journey Medical vs Cue Biopharma
Over the past year DERM returned −8.6% and CUE returned +18.2%; their daily moves had a correlation of 0.03.
DERM −8.6% CUE +18.2%Growth of $1, one year, split-adjusted
| Metric | DERM | CUE |
|---|---|---|
| Price | $6.49 | $25.51 |
| Market cap | $183.2M | $185.3M |
| Today | +0.93% | −7.07% |
| 1 month | −13.1% | −8.5% |
| 6 months | +47.8% | +276.3% |
| Year to date | −15.8% | +178.4% |
| 1 year | −8.1% | +19.8% |
| Revenue growth (YoY) | +18.9% | +166.7% |
| Gross margin | 65.6% | 100.0% |
| Net margin | −1.7% | −1943.2% |
| P/E (TTM) | — | — |
| Price / sales | 2.7× | 4.9× |
| Net cash | -$245.0K | $16.4M |
| Dividend yield | — | — |
| Volatility (60d) | 55.3% | 125.7% |
| Short % of float | 24.3% | 9.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).